HPV Vaccination is a Primary Prevention of Cervical Cancer

Research output: Contribution to journalArticlepeer-review

Abstract

Cervical cancer is the most frequent cancer in women. HPV virus is a carcinogen of cervical cancer, and infection of HPV type 16 and 18 had been encountered in 81% of patients with cervical cancer. Pap smear examination and therapy of precancerous lesion are the secondary preventive measures. There are several disadvantages of secondary prevention, while primary preventions have not yielded satisfactory results. HPV vaccination was part of the new primary prevention, and it has been expected to reduce the incidence rates of cervical cancers of uterus by 81%. HPV vaccination could be administered by all health providers, for women aged 9-26 years who wanted protection against HPV infection. This paper aimed to present problems of the administration of HPV vaccines, along with guidelines for its administration. By broadening the coverage of HPV vaccine administration, it is hoped that there will be a reduction in the incidence rates of cervical cancer in Indonesia.Keywords: prophylactic vaccine, precancerous lesion, HPV type 16 and 18
Original languageEnglish
JournalJournal of the Indonesian Medical Association
Volume57
Issue number5
Publication statusPublished - 2007

Fingerprint Dive into the research topics of 'HPV Vaccination is a Primary Prevention of Cervical Cancer'. Together they form a unique fingerprint.

Cite this